Latest Breaking News On - Single shot chikungunya vaccine - Page 1 : comparemela.com

Valneva Receives EMA s Positive CHMP Opinion for its Chikungunya Vaccine

Valneva Receives EMA s Positive CHMP Opinion for its Chikungunya Vaccine
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomJoshua drummInstituto butantanRichard hatchettJuan carlos jaramilloHealth information for internationalOxford universityEuropean commissionCenters for diseaseVp global communications european investor relationsBrazilian health regulatory agencyEuropean unionCommittee for medicinal products human useHealth canada

Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1.

United kingdomUnited statesJoshua drummInstituto butantanFda tropical disease priority review voucher programExchange commissionDeerfield management companyGlobal communicationsTropical disease priority review voucher programUs centers for diseaseCoalition for epidemic preparedness innovationsUs advisory committee on immunization practicesThird partyValneva reports first quarterPriority review voucherEuronext paris

Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine

Saint-Herblain , January 10, 2024 – Valneva SE today announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and Immunogenicity in children of.

Dominican republicNew yorkUnited statesInstituto butantanJoshua drummJuan carlos jaramilloVp global communications european investor relationsEuropean union horizonBrazilian health regulatory agency anvisaHealth information for internationalEuropean medicines agencyCenters for diseaseOxford university pressOxford universityHealth canadaDrug administration

Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine

Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Dominican republicNew yorkUnited statesJoshua drummJuan carlos jaramilloInstituto butantanHealth canadaDrug administrationVp global communications european investor relationsOxford universityEuropean union horizonCenters for diseaseHealth information for internationalOxford university pressBrazilian health regulatory agency anvisaEuropean medicines agency

Valneva Reports Positive 24-Month Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

Valneva Reports Positive 24-Month Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJuan carlos jaramilloJoshua drummCenters for diseaseOxford university pressHealth canadaHealth information for internationalVp global communications european investor relationsOxford universityReports positiveMonth antibody persistence dataSingle shot chikungunya vaccineEuronext parisAdverse eventSpecial interest